Skyline view, which includes the Washington Monument, of the city of Washington D.C. in the United States.


09.09.2020 - 12.09.2020 8th Joint Meeting of the Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS)

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) joint meeting is being held this year under the name MSWashingtonDC2020. This exciting triennial joint meeting will feature top MS experts from all over the world and provide cutting-edge knowledge about research and therapies focused solely on MS. The scientific program committee is co-chaired by Dr. Benjamin Segal (Ohio State University, USA) and Dr. Maria Pia Amato (University of Florence, Italy).

In 2017, Neurologybytes covered the last ECTRIMS-ACTRIMS joint meeting and reported on exciting sessions about MS treatment, diagnosis, therapeutic advancements, diet, microbiome, and more. In addition, a Teva-sponsored symposium at ECTRIMS-ACTRIMS 2017 about patient disability associated with MS was extensively reported here. Since then, coverage on the annual ECTRIMS meetings have continued, of which the latest included sessions on retinal biomarkers and epigenetics of MS, as well as MS and cardiovascular comorbidities from ECTRIMS 2019.

This year, the program will feature plenary sessions, teaching courses, sessions dedicated for young investigators, sessions for nurses, poster sessions, and “meet the expert” sessions. A detailed program is still under consideration, but is bound to be packed with current and vital topics in MS as well as indispensable discussions and networking opportunities.

Click here to read more on MSWashingtonDC2020 and check for program updates.